News

Zacks Investment Research on MSN18h
Novo Nordisk (NVO) Registers a Bigger Fall Than the Market: Important Facts to Note
In the latest trading session, Novo Nordisk (NVO) closed at $47.00, marking a -6.06% move from the previous day. This change lagged the S&P 500's 0.37% loss on the day. Elsewhere, the Dow saw a ...
NVO Stock Crashes 22% After 2025 View Cut: More Downside Ahead?
Novo Nordisk stock plunges 22% after slashing 2025 sales and profit outlooks, citing weak GLP-1 drugs' uptake and rising ...
The Zacks Analyst Blog Highlights Tempus AI, NVIDIA, AstraZeneca and Novo Nordisk
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Nasdaq22d
The Zacks Analyst Blog Highlights SAP SE, Novo Nordisk, Thermo ... - Nasdaq
Today's Research Daily features new research reports on 16 major stocks, including SAP SE, Novo Nordisk A/S and Thermo Fisher Scientific Inc., as well a micro-cap stock FONAR Corp.
Novo Nordisk shares extend losses, erasing nearly all gains since Wegovy launch
Shares in Novo Nordisk fell as much as 6% on Friday to their lowest since August 2021, extending recent losses to wipe out ...
Novo Nordisk Stock Hits New 52-Week Low Amid Profit Warning: What Investors Need To Know
Shares of Novo Nordisk are trading lower Wednesday morning. The stock is extending a dramatic sell-off from Tuesday's session ...
The Obesity Bubble Has Finally Burst. Novo Nordisk Shares Drop 21%.
The drugmaker unexpectedly cuts its full-year guidance, citing lower sales expectations for its blockbuster drugs Wegovy and ...